ReviewRSC medicinal chemistry2022

A concise review on hPXR ligand-recognizing residues and structure-based strategies to alleviate hPXR transactivation risk.

Tao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.